Shinozuka K et al (2013) Stem cells for neurovascular repair in stroke. J Stem Cell Res Ther 4(4):12912
PubMed PubMed Central Google Scholar
Cao W et al (2015) Effectiveness and safety of autologous bone marrow stromal cells transplantation after ischemic stroke: a meta-analysis. Med Sci Monit 21:2190–2195
Article PubMed PubMed Central Google Scholar
Roy-O’Reilly M et al (2014) Sex differences in stroke: the contribution of coagulation. Exp Neurol 259:16–27
Article CAS PubMed PubMed Central Google Scholar
Hankey GJ (2017) Stroke. Lancet 389(10069):641–654
Kleindorfer DO et al (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the american heart association/american stroke association. Stroke 52(7):e364–e467
Phipps MS, Cronin CA (2020) Management of acute ischemic stroke. BMJ 368:l6983
Guo X et al (2023) Ischemia reperfusion injury induced blood brain barrier dysfunction and the involved molecular mechanism. Neurochem Res 48(8):2320–2334
Article CAS PubMed Google Scholar
Zhu H et al (2022) Interleukins and ischemic stroke. Front Immunol 13:828447
Article CAS PubMed PubMed Central Google Scholar
Sun MS et al (2018) Free Radical Damage in Ischemia-Reperfusion Injury: An Obstacle in Acute Ischemic Stroke after Revascularization Therapy. Oxid Med Cell Longev 2018:3804979
Article PubMed PubMed Central Google Scholar
Su Z et al (2022) Pathophysiology of ischemic stroke: noncoding RNA role in oxidative stress. Oxid Med Cell Longev 2022:5815843
Article PubMed PubMed Central Google Scholar
Kleindorfer D et al (2004) Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 35(2):e27–e29
Article CAS PubMed Google Scholar
Hoang DM et al (2022) Stem cell-based therapy for human diseases. Signal Transduct Target Ther 7(1):272
Article PubMed PubMed Central Google Scholar
Doeppner TR et al (2015) Extracellular vesicles improve post-stroke neuroregeneration and prevent postischemic immunosuppression. Stem Cells Transl Med 4(10):1131–1143
Article CAS PubMed PubMed Central Google Scholar
Hughey CC et al (2013) Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart. Cardiovasc Diabetol 12:128
Article PubMed PubMed Central Google Scholar
Schmehl J et al (2021) Intravascular application of labelled cell spheroids: an approach for ischemic peripheral artery disease. Int J Mol Sci 22(13):6831
Article CAS PubMed PubMed Central Google Scholar
Wang LQ et al (2014) Timing and dose regimens of marrow mesenchymal stem cell transplantation affect the outcomes and neuroinflammatory response after ischemic stroke. CNS Neurosci Ther 20(4):317–326
Article CAS PubMed PubMed Central Google Scholar
Shinozuka K et al (2013) Stem cell transplantation for neuroprotection in stroke. Brain Sci 3(1):239–261
Article PubMed PubMed Central Google Scholar
Ishizaka S et al (2013) Intra-arterial cell transplantation provides timing-dependent cell distribution and functional recovery after stroke. Stroke 44(3):720–726
Guillamat-Prats R (2021) The role of MSC in wound healing scarring and regeneration. Cells 10(7):1729
Article CAS PubMed PubMed Central Google Scholar
Shen Z et al (2021) Effects of mesenchymal stem cell-derived exosomes on autoimmune diseases. Front Immunol 12:749192
Article CAS PubMed PubMed Central Google Scholar
Chang D et al (2021) Application of mesenchymal stem cell sheet to treatment of ischemic heart disease. Stem Cell Res Ther 12(1):384
Article PubMed PubMed Central Google Scholar
Psaraki A et al (2022) Extracellular vesicles derived from mesenchymal stem/stromal cells: the regenerative impact in liver diseases. Hepatology 75(6):1590–1603
Article CAS PubMed Google Scholar
Lin Y et al (2022) Huc-MSC-derived exosomes modified with the targeting peptide of aHSCs for liver fibrosis therapy. J Nanobiotechnology 20(1):432
Article CAS PubMed PubMed Central Google Scholar
Liu G et al (2022) Therapeutic efficacy of human mesenchymal stem cells with different delivery route and dosages in rat models of spinal cord injury. Cell Transpl 31:9636897221139734
Huang J et al (2022) Mesenchymal stem cells-derived exosomes ameliorate ischemia/reperfusion induced acute kidney injury in a porcine model. Front Cell Dev Biol 10:899869
Article PubMed PubMed Central Google Scholar
Wang XX et al (2022) NADPH is superior to NADH or edaravone in ameliorating metabolic disturbance and brain injury in ischemic stroke. Acta Pharmacol Sin 43(3):529–540
Article CAS PubMed Google Scholar
Röther J et al (2013) Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities. Cerebrovasc Dis 35(4):313–319
Chen J et al (2001) Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke 32(4):1005–1011
Article CAS PubMed Google Scholar
Liu W et al (2022) Edaravone ameliorates cerebral ischemia-reperfusion injury by downregulating ferroptosis via the Nrf2/FPN pathway in rats. Biol Pharm Bull 45(9):1269–1275
Article CAS PubMed Google Scholar
Kikuchi K et al (2009) Edaravone attenuates cerebral ischemic injury by suppressing aquaporin-4. Biochem Biophys Res Commun 390(4):1121–1125
Article CAS PubMed Google Scholar
Li Y et al (2021) Strategies to improve the efficiency of transplantation with mesenchymal stem cells for the treatment of ischemic stroke: a review of recent progress. Stem Cells Int 2021:9929128
Article PubMed PubMed Central Google Scholar
Guo Y et al (2021) Progress in mesenchymal stem cell therapy for ischemic stroke. Stem Cells Int 2021:9923566
Comments (0)